315 related articles for article (PubMed ID: 11022008)
1. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
Zhu Yd; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
Virology; 2000 Oct; 276(1):202-13. PubMed ID: 11022008
[TBL] [Abstract][Full Text] [Related]
2. Experimental measles. II. Infection and immunity in the rhesus macaque.
Zhu YD; Heath J; Collins J; Greene T; Antipa L; Rota P; Bellini W; McChesney M
Virology; 1997 Jun; 233(1):85-92. PubMed ID: 9229928
[TBL] [Abstract][Full Text] [Related]
3. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of rhesus macaques with a recombinant measles virus expressing interleukin-12 alters humoral and cellular immune responses.
Hoffman SJ; Polack FP; Hauer DA; Singh M; Billeter MA; Adams RJ; Griffin DE
J Infect Dis; 2003 Nov; 188(10):1553-61. PubMed ID: 14624382
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of a canine distemper-measles and a standard measles vaccine for immunization of rhesus macaques (Macaca mulatta).
Christe KL; McChesney MB; Spinner A; Rosenthal AN; Allen PC; Valverde CR; Roberts JA; Lerche NW
Comp Med; 2002 Oct; 52(5):467-72. PubMed ID: 12405642
[TBL] [Abstract][Full Text] [Related]
6. Maternal antibody inhibits both cellular and humoral immunity in response to measles vaccination at birth.
Premenko-Lanier M; Hodge G; Rota P; Tamin A; Bellini W; McChesney M
Virology; 2006 Jul; 350(2):429-32. PubMed ID: 16569419
[TBL] [Abstract][Full Text] [Related]
7. A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys.
Skiadopoulos MH; Surman SR; Riggs JM; Collins PL; Murphy BR
J Virol; 2001 Nov; 75(21):10498-504. PubMed ID: 11581420
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies.
Durbin AP; Cho CJ; Elkins WR; Wyatt LS; Moss B; Murphy BR
J Infect Dis; 1999 Jun; 179(6):1345-51. PubMed ID: 10228053
[TBL] [Abstract][Full Text] [Related]
9. Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vector.
Kovarik J; Gaillard M; Martinez X; Bozzotti P; Lambert PH; Wild TF; Siegrist CA
Virology; 2001 Jun; 285(1):12-20. PubMed ID: 11414801
[TBL] [Abstract][Full Text] [Related]
10. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies.
van Binnendijk RS; Poelen MC; van Amerongen G; de Vries P; Osterhaus AD
J Infect Dis; 1997 Mar; 175(3):524-32. PubMed ID: 9041322
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
[TBL] [Abstract][Full Text] [Related]
12. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
[TBL] [Abstract][Full Text] [Related]
13. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
[TBL] [Abstract][Full Text] [Related]
14. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
[TBL] [Abstract][Full Text] [Related]
15. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody.
Polack FP; Auwaerter PG; Lee SH; Nousari HC; Valsamakis A; Leiferman KM; Diwan A; Adams RJ; Griffin DE
Nat Med; 1999 Jun; 5(6):629-34. PubMed ID: 10371500
[TBL] [Abstract][Full Text] [Related]
16. Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.
Polack FP; Lydy SL; Lee SH; Rota PA; Bellini WJ; Adams RJ; Robinson HL; Griffin DE
Clin Vaccine Immunol; 2013 Feb; 20(2):205-10. PubMed ID: 23239799
[TBL] [Abstract][Full Text] [Related]
17. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles.
Polack FP; Lee SH; Permar S; Manyara E; Nousari HG; Jeng Y; Mustafa F; Valsamakis A; Adams RJ; Robinson HL; Griffin DE
Nat Med; 2000 Jul; 6(7):776-81. PubMed ID: 10888926
[TBL] [Abstract][Full Text] [Related]
18. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.
Gans H; Yasukawa L; Rinki M; DeHovitz R; Forghani B; Beeler J; Audet S; Maldonado Y; Arvin AM
J Infect Dis; 2001 Oct; 184(7):817-26. PubMed ID: 11528592
[TBL] [Abstract][Full Text] [Related]
20. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
Earl PL; Wyatt LS; Montefiori DC; Bilska M; Woodward R; Markham PD; Malley JD; Vogel TU; Allen TM; Watkins DI; Miller N; Moss B
Virology; 2002 Mar; 294(2):270-81. PubMed ID: 12009868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
